Real-time enrollment status for this low grade upper tract urothelial carcinoma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:27 PM UTC
| NCT Number | NCT07265947 |
| Recruiting Status | Recruiting |
| Condition | Low Grade Upper Tract Urothelial Carcinoma |
| Phase | PHASE2 |
| Target Enrollment | 230 participants |
| Active Locations | 23 sites in the US |
| Sponsor | Tyra Biosciences, Inc |
| Last Updated on CT.gov | October 2, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT07265947 is currently recruiting participants. This phase2 study for low grade upper tract urothelial carcinoma is actively seeking new participants at 23 locations across the United States. The study is sponsored by Tyra Biosciences, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07265947 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07265947 was last updated 1 week ago (October 2, 2026). HelloStudys verifies this status automatically.